STOCK TITAN

Inspire Medical Systems, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) announced its participation in the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 8:15 a.m. Pacific Time. The event will take place at the Westin St. Francis Hotel in San Francisco, CA. A live webcast of the presentation will be available, with a replay accessible for two weeks on Inspire's Investor website. Inspire specializes in minimally invasive solutions for obstructive sleep apnea, including its FDA-approved Inspire therapy, a neurostimulation technology for moderate to severe cases.

Positive
  • None.
Negative
  • None.

MINNEAPOLIS, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at the Westin St. Francis Hotel in San Francisco, CA.

Inspire is scheduled to present at 8:15 a.m. Pacific Time. The presentation will be accessible via a live webcast here.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443


FAQ

When is Inspire Medical Systems presenting at the J.P. Morgan Healthcare Conference?

Inspire Medical Systems is scheduled to present on January 9, 2023, at 8:15 a.m. Pacific Time.

Where can I watch the Inspire Medical Systems presentation?

The presentation will be accessible via a live webcast on Inspire's Investor website.

What is the focus of Inspire Medical Systems?

Inspire Medical Systems focuses on developing and commercializing minimally invasive solutions for obstructive sleep apnea.

What is the FDA-approved treatment offered by Inspire Medical Systems?

Inspire offers Inspire therapy, the first FDA-approved neurostimulation technology for treating moderate to severe obstructive sleep apnea.

How long will the webcast replay be available after the presentation?

The webcast replay will be available for two weeks following the presentation in the Event Archive section of Inspire's Investor website.

Inspire Medical Systems, Inc.

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Stock Data

5.58B
29.36M
1.95%
113.89%
6.52%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
GOLDEN VALLEY